Determination of plasma levels of exemestane (FCE 24304), a new irreversible aromatase inhibitor, using liquid chromatography/thermospray mass spectrometry
β Scribed by C. Allievi; P. Zugnoni; M. Strolin Benedetti; P. Dostert
- Book ID
- 102379677
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 437 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1076-5174
No coin nor oath required. For personal study only.
β¦ Synopsis
A high performaoce liquid chromatographic mass spectrometric method with thermospray ionization for the determination of concentratioas of exemestane (dmethylena~drosta-1,4-diene-3,17dione, FCE 24304) in human plasma has been developed. The sensitivity of the method allowed the determination of exemestane concentrations as low as 1 ng d-'. A suitable internal standard was used for quantification. The intraday precision (relative standard deviation, RS.D.) ranged from 16.3% near to the lower limit of quaatilkation to 0.3% close to the upper end of the calibration graph. The mean accuracy of the method was found to be 97.8% (RS.D. = 7%). Unlike a previously developed gas chromatographic/mass spectrometric method, the new method proved to be suitable for the determination of unchanged drug plasma levels in exemestane-treated subjects.
π SIMILAR VOLUMES
L-654,066 is a new 5 alpha-reductase inhibitor. A sensitive and specific assay based on combined liquid chromatography/mass spectrometry has been developed for the determination of this drug candidate in plasma. The analyte was isolated from plasma by solid-phase extraction on a C-18 cartridge. A re